BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34856512)

  • 21. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
    Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
    Mattes MD; Moshchinsky AB; Ahsanuddin S; Rizk NP; Foster A; Wu AJ; Ashamalla H; Weber WA; Rimner A
    Clin Lung Cancer; 2015 Nov; 16(6):e253-8. PubMed ID: 26163919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Resection time and number of detected colorectal lymph nodes in resection specimens with carcinoma].
    Schmidt MB; Engel UH; Mogensen AM; Petersen LN; Bülow S; Wied U; Holck S;
    Ugeskr Laeger; 2009 Aug; 171(35):2458-62. PubMed ID: 19732530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
    Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Bogaert J; Maes A; Deneffe GJ; Nackaerts KL; Verschakelen JA; Lerut TE; Mortelmans LA; Demedts MG
    J Clin Oncol; 1998 Jun; 16(6):2142-9. PubMed ID: 9626214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal Lymph Node Examination and Adjuvant Chemotherapy for Stage I Lung Cancer.
    Dai J; Liu M; Yang Y; Li Q; Song N; Rocco G; Sihoe ADL; Gonzalez-Rivas D; Suen HC; He W; Duan L; Fan J; Zhao D; Wang H; Zhu Y; Chen C; Diasio RB; Jiang G; Yang P; Zhang P
    J Thorac Oncol; 2019 Jul; 14(7):1277-1285. PubMed ID: 31009811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
    Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
    Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer.
    Jonnalagadda S; Smith C; Mhango G; Wisnivesky JP
    Chest; 2011 Aug; 140(2):433-440. PubMed ID: 21292754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
    Takamochi K; Yoshida J; Murakami K; Niho S; Ishii G; Nishimura M; Nishiwaki Y; Suzuki K; Nagai K
    Lung Cancer; 2005 Feb; 47(2):235-42. PubMed ID: 15639722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.
    Ahrendt SA; Yang SC; Wu L; Roig CM; Russell P; Westra WH; Jen J; Brock MV; Heitmiller RF; Sidransky D
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):466-73; discussion 473-4. PubMed ID: 11882817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult lymph node metastasis in radiologic stage I non-small cell lung cancer: The role of endobronchial ultrasound.
    Kukhon FR; Lan X; Helgeson SA; Arunthari V; Fernandez-Bussy S; Patel NM
    Clin Respir J; 2021 Jun; 15(6):676-682. PubMed ID: 33630405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of surgical resection for pathologic N0 and Nx non-small cell lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; Spencer D; O'Brien T
    J Thorac Oncol; 2010 Feb; 5(2):191-6. PubMed ID: 20035237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
    Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
    Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
    Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
    Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases.
    Benlloch S; Galbis-Caravajal JM; Alenda C; Peiró FM; Sanchez-Ronco M; Rodríguez-Paniagua JM; Baschwitz B; Rojas E; Massutí B
    Ann Oncol; 2009 Jan; 20(1):91-7. PubMed ID: 18664559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodal size ranking as a predictor of mediastinal involvement in clinical early-stage non-small cell lung cancer.
    Caupena C; Costa R; Pérez-Ochoa F; Call S; Jaen À; Rami-Porta R; Obiols C; Esteban L; Albero-González R; Luizaga LA; Serra M; Belda J; Tarroch X; Sanz-Santos J
    Medicine (Baltimore); 2019 Dec; 98(50):e18208. PubMed ID: 31852077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of Patients With Stages I and II Non-Small Cell Lung Cancer With Nodal Micrometastases.
    Gwóźdź P; Pasieka-Lis M; Kołodziej K; Pankowski J; Banaś R; Wiłkojć M; Zieliński M
    Ann Thorac Surg; 2018 May; 105(5):1551-1557. PubMed ID: 29305849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?
    Deng HY; Zhou J; Wang RL; Jiang R; Zhu DX; Tang XJ; Zhou Q
    Ann Surg Oncol; 2020 Feb; 27(2):472-480. PubMed ID: 31617120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial Cancer.
    Davidson BA; Ehrisman J; Abbott S; Harmon Z; Secord AA; Berchuck A; Lee PS; Valea FA; Li X; Havrilesky LJ; Hall AHS
    Int J Gynecol Pathol; 2018 May; 37(3):252-255. PubMed ID: 28700428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer.
    Kneuertz PJ; Cheufou DH; D'Souza DM; Mardanzai K; Abdel-Rasoul M; Theegarten D; Moffatt-Bruce SD; Aigner C; Merritt RE
    J Thorac Cardiovasc Surg; 2019 Nov; 158(5):1457-1466.e2. PubMed ID: 31623811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Predictive Model for Lymph Node Involvement with Malignancy on PET/CT in Non-Small-Cell Lung Cancer.
    Mattes MD; Weber WA; Foster A; Moshchinsky AB; Ahsanuddin S; Zhang Z; Shi W; Rizk NP; Wu AJ; Ashamalla H; Rimner A
    J Thorac Oncol; 2015 Aug; 10(8):1207-12. PubMed ID: 26200276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.